Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Símbolo desconocido
Fecha:
Ordernar por:
FechaHoraFuenteTítuloSímboloCompañía
06/06/202405:33Business WireInQuik et CMC unissent leurs forces pour stimuler l’innovation dans la construction de ponts
06/06/202405:32Business WireInQuik und CMC machen sich gemeinsam für Innovationen im Brückenbau stark
06/06/202405:30GlobeNewswire Inc.Freight Technologies Adds 26 New Customers and 149 New Carriers in 2024NASDAQ:FRGTFreight Technologies Inc
06/06/202405:30GlobeNewswire Inc.Seres Therapeutics Enters Into Memorandum of Understanding For Vowst™ Asset Sale to Nestlé Health ScienceNASDAQ:MCRBSeres Therapeutics Inc
06/06/202405:30Business WireStone-Goff Portfolio Company JSI Acquires Inteserra
06/06/202405:30Business WireKalVista Pharmaceuticals Presents Data at Eastern Allergy Conference 2024 and the Japanese Dermatological Association 2024NASDAQ:KALVKalVista Pharmaceuticals Inc
06/06/202405:30Business WirenVent to Acquire TrachteNYSE:NVTnVent Electric PLC
06/06/202405:30PR Newswire (US)Symmetry Systems Recognized as a Strong Performer in the 2024 Gartner® Peer Insights™ Voice of the Customer for Data Security Posture Management report
06/06/202405:30PR Newswire (US)Nick Jones Appointed SVP and GM Commercial Solutions
06/06/202405:30PR Newswire (Canada)North Dakota DOT Selects Quarterhill's iTHEIA™ AI Classification System for Traffic MonitoringTSX:QTRHQuarterhill Inc
06/06/202405:30PR Newswire (US)Rohde & Schwarz and VIAVI Offer Joint Network Test Solutions Supporting Open Radio Commercialization and InnovationNASDAQ:VIAVViavi Solutions Inc
06/06/202405:30PR Newswire (US)CNOOC Limited Made Major Discovery in Western South China Sea
06/06/202405:29GlobeNewswire Inc.Zealand Pharma announces that Boehringer Ingelheim will present positive results from Phase 2 trial with survodutide in MASH at EASLTG:22ZZealand Pharma AS
06/06/202405:26PR Newswire (US)Waterdrop Inc. Reports 2024 Q1 Revenue of RMB 704.7 Million, net profit rises 62.2% year-on-year, Sustaining Profitability for Nine Consecutive QuartersNYSE:WDHWaterdrop Inc
06/06/202405:25Edgar (US Regulatory)Form 8-K - Current reportNYSE:ALITAlight Inc
06/06/202405:25Alliance NewsAlliance NewsAIM WINNERS & LOSERS: Strip Tinning wins GBP43.0 million contract
06/06/202405:25GlobeNewswire Inc.Parsons Receives Sustainability Award from Yukon GovernmentNYSE:PSNParsons Corporation
06/06/202405:22Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:INDVIndivior PLC
06/06/202405:22Alliance NewsAlliance NewsJadestone Energy to commence operations at Akatara in coming weeksLSE:JSEJadestone Energy Plc
06/06/202405:22PR Newswire (US)Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revolutionizes Rapid Disease Detection and Management
06/06/202405:20GlobeNewswire Inc.HSBC - DEALINGS DISCLOSURE - XP POWER LIMITED
06/06/202405:18Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:HCATHealth Catalyst Inc
06/06/202405:15GlobeNewswire Inc.Nevada Copper Provides Update on Financing Efforts and LiquidityTSX:NCUNevada Copper Corp
06/06/202405:15Business Wire Perfect Corp. Announces the CEO’s Increase in ShareholdingNYSE:PERFPerfect Corp
06/06/202405:14Business WireMNC Capital Increases All-Cash Offer to Acquire Vista Outdoor to $39.50 Per Share
06/06/202405:10GlobeNewswire Inc.NIO Inc. Reports Unaudited First Quarter 2024 Financial ResultsNYSE:NIONIO Inc
06/06/202405:10Business WireGFOA 2024: Euna Solutions to Highlight New Partnerships and Showcase Product Innovations for Public Sector Financial Management
06/06/202405:08Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNYSE:QSQuantumscape Corp
06/06/202405:07Alliance NewsAlliance NewsS&U profit falls in first quarter amid higher impairment provisioningLSE:SUSS & U Plc
06/06/202405:07Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:SILOSilo Pharma Inc